THALASSEMIA GENOTYPING IN PATIENTS WITH ABNORMAL COMPLETE BLOOD COUNT USING MULTICOLOR MELTING-CURVE REAL-TIME PCR

Văn Thạo Tạ 1,, Kim Chi Dương 1
1 Hanoi Medical University

Main Article Content

Abstract

Objectives: To determine the carrier rate, mutation spectrum (19 variants), and hematological characteristics in patients with suspected thalassemia based on abnormal complete blood count (CBC) in Northern Vietnam, using multichannel melting curve real-time PCR. Methods: Cross-sectional descriptive study on 116 patients (01/2023–06/2025) at Chemedic Laboratory. Genomic DNA was extracted from peripheral blood and genotyped using multichannel fluorescent real-time PCR with melting curve analysis (Thalassemia Gene Assay kit, Yaneng Bioscience, IVD-certified) on CFX96 Touch/DTprime-5 systems. Data analyzed with OriginPro 2024; Mann-Whitney U test for hematological comparisons. Results: Carrier rate 50.9% (59/116); α-thalassemia 29.3%, β-thalassemia 18.9%, α+β co-inheritance 2.6%. Total 66 mutation events: --SEA 37.9%, HbE 18.2%, CD41/42 12.1%. Carriers exhibited higher RBC (5.41 ± 0.55 vs 4.87 ± 1.01 ×10¹²/L; p=0.006), lower MCHC (295 ± 19.9 vs 306 ± 21.7 g/L; p=0.003), and higher RDW-CV (17.4 ± 3.2 vs 16.6 ± 4.1%; p=0.056). Conclusion: High thalassemia carrier prevalence with --SEA and HbE predominance aligns with Southeast Asian epidemiology. Multichannel melting curve real-time PCR demonstrates high sensitivity (>99%) for simultaneous detection of 24 mutations, facilitating community screening and premarital genetic counseling.

Article Details

References

1. Weatherall D.J. (2011). The inherited disorders of hemoglobin: an increasingly neglected global health burden. Indian J Med Res, 134, 493-7.
2. Taher A.T., Weatherall D.J., Cappellini M.D. và cộng sự. (2018). Thalassaemia. Lancet, 391(10116), 155-67.
3. Galanello R., Origa R. (2010). Beta-thalassemia. Orphanet J Rare Dis, 5, 11.
4. Modell B., Darlison M. (2008). Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ, 86(6), 480-7.
5. International Thalassemia Federation. (2022). Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd ed. Nicosia: IFT Publications.
6. World Health Organization. (2008). Management of haemoglobin disorders: report of a joint WHO-TIF meeting. Geneva: WHO.
7. Cappellini M.D., Cohen A., Porter J. và cộng sự. (2014). Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd ed. Nicosia: Thalassaemia International Federation.
8. Cao A., Galanello R. (2010). Beta-thalassemia. Genet Med, 12(2), 61-76.